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the MHC as well as multiple minor histocompatibility
loci. While all components of the innate and adaptive
immune systems participate in graft rejection, models
in which T cell- or CD4 T cell-deficient mice indefinitely
accept allografts demonstrate the paramount impor-
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tance of T lymphocytes and particularly CD4 T cells inPhiladelphia, Pennsylvania 19104
this process (Rosenberg and Singer, 1992). Host T cells2 Department of Medicine
can be activated in response to an allogeneic stimulusDivision of Immunology
by one of two separate mechanisms (Batchelor andBeth Israel Deaconess Medical Center
Lechler, 1982). Direct allorecognition defines the re-Harvard Medical School
sponse of host T cells recognizing intact donor MHCBoston, Massachusetts 02215
molecules present on the surface of donor-derived anti-
gen-presenting cells (APCs). In the indirect pathway of
allorecognition, host T cells respond to processed do-The alloimmune response can be divided into specific
nor-derived peptides bound to syngeneic MHC mole-junctures where critical decisions between tolerance
cules and presented in a self-restricted manner.and immunity are made which define the outcome
Studies over the past twenty years suggest separateof the transplant. At these “decision nodes” various
but complementary roles for these two pathways of allo-cytokines direct alloresponsive T cells to develop ei-
recognition in rejection and tolerance. This does notther a proinflammatory response aimed at graft de-
appear to be the result of differences in the quality ofstruction or an immunoregulatory response facilitating
the T cell response, or the cytokines elicited, but rathergraft acceptance. This review will focus on the role of
is based on differences in cell quantity and locale. Forthese cytokines in influencing the progression of an
example, donor-derived APCs, primarily dendritic cells,alloimmune response leading ultimately to either allo-
are present in grafted tissues as passenger leucocytesgraft survival or rejection.
that migrate posttransplant to host lymphoid tissues
where they directly stimulate host T cells. Dendritic cells
are extremely powerful activators of naive T cells, andIntroduction
this, coupled with the very large frequency of cells exhib-Self-tolerance refers to the normal homeostatic balance
iting direct alloreactivity, has led to the concept that thein which the immune system exists without any patho-
direct pathway of allorecognition is dominant duringlogic response to self-antigens. Similarly, acquired trans-
acute rejection (Game and Lechler, 2002; Suchin et al.,plant tolerance refers to the absence of a pathologic
2001; Womer et al., 2001).immune response to the allograft without the need
As migratory dendritic cells are relatively short-livedfor chronic, nonspecific immunosuppression. In other
after transplantation, the role of direct alloreactivity maywords, the host’s immune system should be fully com-
be temporally limited, allowing the indirect pathway topetent to respond adequately to further antigenic chal-
predominate in the later stages of the allograft response.lenge without targeting the transplanted organ or tissue.
Evidence in favor of this includes the findings of largeAlthough the attainment of true transplantation toler-
numbers of indirectly reactive T cells (by limiting dilutionance (with acceptable treatment toxicity) in the clinical
analysis) in patients undergoing chronic rejection, butsetting remains elusive, it can often be induced in a
not in controls with good graft function, and the require-
variety of rodent models. In these settings, intense in-
ment for indirect allorecognition to provide B cell help
vestigation of the mechanisms involved has led to a
for alloantibody production, a key feature of chronic
greater understanding of the requirements for tolerance rejection (Hornick et al., 2000; Pettigrew et al., 1998).
and the obstacles to be overcome if long-term allograft Nonetheless, direct alloreactivity may not necessarily
acceptance is to be achieved in the future. be limited to the early phases of the allograft response.
As with other immune responses, cytokines play an Donor endothelial cells, expressing many of the same
integral role in alloimmunity, and the pattern of cytokine costimulatory and adhesion molecules found on den-
expression is central to the mechanisms which regulate dritic cells, are able to directly activate recipient CD8
the development of immune tolerance to transplanted T cells (Kreisel et al., 2002). As donor endothelial cells
tissues. This review will provide an overview of current persist for the life of the graft, they may provide a con-
concepts of alloimmunity and allotolerance with an em- stant source of stimulation for directly alloreactive
phasis on the part played by cytokines in these pro- T cells. It is also important to keep in mind that the
cesses and discuss strategies which have been em- indirect pathway of allorecognition may be utilized by
ployed to exploit this knowledge as a means of inducing regulatory T cells which are required to maintain toler-
transplantation tolerance. ance in a number of different experimental transplant
models (reviewed in Cobbold and Waldmann, 1998; fur-
Overview of Allorecognition and Graft Rejection ther discussion below).
Allograft rejection is primarily driven by the ability of
host T cells to recognize polymorphisms encoded within Overview of Peripheral Tolerance
One of the most successful experimental strategies to
induce allograft acceptance is to create a state of mixed*Correspondence: turka@mail.med.upenn.edu
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hematopoietic chimerism (Sykes, 2001). This strategy and homeostasis in vivo have not been clearly defined,
in vitro systems indicate an important role for cytokines,exploits the natural homeostatic mechanisms used to
including IL-4 and granulocyte-macrophage colony-create self-tolerance during T cell development in the
stimulating factor (GM-CSF) in particular, in promotingthymus. Mixed chimerism and other strategies of central
the development of these cells from bone marrow- and(i.e., thymic) tolerance appear to act almost exclusively
peripheral blood-derived precursors. Type-1 interfer-via deletional mechanisms, with scant if any evidence
ons, which are secreted from a variety of different cellfor anergy or regulation (Nikolic and Sykes, 1997). As a
types in response to inflammatory damage, can alsoresult, the requirement for cytokines, as they may exist,
lead to DC development in vitro. Infection or tissue dam-in this process has not been investigated in depth. Thus,
age (such as takes place in the context of transplanta-for the purposes of this review, we will restrict our dis-
tion) promote the maturation of DCs. In contrast to theircussion to the role of cytokines in the regulation of pe-
immature counterparts, mature DCs can efficiently in-ripheral tolerance, i.e., strategies primarily targeted at
duce T cell expansion and differentiation, which hasmature T cells in secondary lymphoid organs.
led to the emergence of a model whereby infection orIt is conceptually useful to divide peripheral trans-
inflammatory tissue damage helps provide the dangerplantation tolerance into two distinct but not mutually
signals required for the development of an immune re-exclusive temporal phases (Li et al., 2001b). The induc-
sponse. The importance of DC maturation in the contexttion phase encompasses events which occur immedi-
of transplantation is illustrated by studies showing thatately posttransplant when a large number of allorespon-
immunization of recipients with immature DCs from thesive T cells are stimulated by graft antigens presented
same donor strain prolongs subsequent murine heartby either donor or host APCs. The development of such
allograft survival in a donor-specific fashion (Lutz et al.,a robust immune response will eventually lead to acute
2000; O’Connell et al., 2002).graft rejection unless mechanisms are set in place which
A number of microbial products such as LPS andhold the inflammatory process in check. Thus, the induc-
bacterial DNA as well as necrotic cell products such astion phase of tolerance typically is characterized by
heat shock proteins have been reported to provide suchdepletion or ignorance of alloreactive T cells with an
an activating stimulus for DCs. These diverse stimuli areimplicit role for a number of different cytokines.
recognized by members of the Toll-like receptor familyOnce this initial acute immune response has been
(TLRs) expressed on the surface of DCs. They promoterestricted, the threat of rejection persists unless the tol-
DC maturation through activation of a variety of signal-erant state is maintained. The maintenance phase of
ing cascades involving adaptor proteins such as MyD88allograft tolerance is an active process of T cell-medi-
and TRAF family members leading to NF-B-mediatedated regulation, which suppresses the potentially injuri-
transcription (Dunne and O’Neill, 2003; Kobayashi etous graft-reactive T cells. While there has long been a
al., 2003). These signaling events in turn lead to thegeneral acceptance of the requirement of active immu-
upregulation of T cell costimulatory molecules includingnoregulatory mechanisms for the maintenance of trans-
CD40, CD80, and CD86 as well as the secretion of cyto-plantation tolerance, it is only recently that such mecha-
kines such as IL-12 and TNF (Akira et al., 2001). Thenisms have been identified and characterized more
importance of this sequence of events in the initiationclosely (Wood and Sakaguchi, 2003).
of an alloresponse has been highlighted by a recent
report demonstrating the critical role of MyD88 expres-
Role of Cytokines in the Response to Allografts sion in acute allograft rejection. In this report, minor
From the above considerations, it is clear that rejection antigen-mismatched allografts were not rejected when
and tolerance can be considered alternative outcomes both donor and recipient mice were MyD88 deficient.
of the allograft response, i.e., host encounter with allo- Prolonged graft survival was associated with a de-
antigens. Once activated, CD4 T cells primarily direct creased number of phenotypically mature DCs found in
the progression of the response by secreting cytokines draining lymph nodes as well as a reduced capacity for
which activate, expand, and/or recruit other effector priming of alloreactive T cells (Goldstein et al., 2003). It
cells such as macrophages and CD8 T cells, B cells, also has been reported that in vitro manipulation of DCs
and NKT T cells. The primary consideration is defining with low doses of GM-CSF or with IL-10 renders the
key junctures at which alternate outcomes are favored cells resistant to maturation and can facilitate prolonged
and determining the parameters that dictate the deci- allograft survival (Lutz et al., 2000; Mitra et al., 1995).
sion ultimately made by the T cell. Here, we consider Several mechanisms have been proposed by which
five such decision nodes and will examine the role immature DCs can promote tolerance (Figure 1) (Steinman
of cytokines in these fate determinations. They are et al., 2003). First, immature DCs constitutively express
APC maturation, T helper cell expansion, T cell survival, only very low (or absent) levels of T cell costimulatory
T helper cell differentiation, and regulatory T cell homeo- molecules such as CD80/86 and CD40 as well as a rela-
stasis. The first four events largely take place during the tively low level of MHC complexes on the cell surface.
induction phase of tolerance while the latter is likely of Moreover, immature DCs do not secrete significant lev-
primary importance during the maintenance phase. els of proinflammatory cytokines such as IL-12 and
APC Maturation TNF. Lack of appropriate costimulation may induce
Dendritic cells (DCs) are found in most peripheral tissues T cell anergy or apoptosis, clearly favoring tolerance.
(Banchereau and Steinman, 1998) and, as noted above, However, the relevance of this observation to in vivo
migrate immediately posttransplant to regional lymph tolerance may be questioned by the fact that, as op-
nodes where the host response to the allograft is then posed to naive T cells, activation of memory T cells
is relatively independent of costimulation (Harris andinitiated. While the requirements for DC development
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Figure 1. Dendritic Cell Maturation Determines the Fate of Responding CD4 T Cells
Immature DCs can induce a number of responses from CD4 T cells which are conducive to tolerance. These include anergy, apoptosis, or
differentiation into a regulatory T cell producing immunosuppressive cytokines such as IL-10. Mature DCs, on the other hand, express elevated
levels of costimulatory molecules and secrete proinflammatory cytokines such as IL-12. This allows mature DCs to efficiently prime CD4
cells to differentiate into Th1 type effector cells secreting IL-2 and IFN-.
Ronchese, 1999) and otherwise unmanipulated inbred tolerance to allogeneic fetuses. While it was originally
postulated that IDO acted by depriving T cells of a requi-mice contain substantial numbers of memory T cells
(Lee et al., 1996), which can exhibit crossreactivity with site growth factor (tryptophan) (Mellor and Munn, 1999),
more recent studies indicate that it is the tryptophanalloantigens (Adams et al., 2003) .
Second, and perhaps more intriguing, is the reported metabolites themselves which exert a cytotoxic effect
on T cells (Frumento et al., 2002; Terness et al., 2002).induction of a regulatory T cell phenotype by repeated
stimulation with immature allogeneic DCs (Jonuleit et Stimulation of mature IDO expressing DCs with IFN-
results in downregulation of this enzyme, an effect whichal., 2000). These induced regulatory T cells (Tr1 cells)
appear to be a distinct population of cells from those is inhibited by the presence of IL-10 (Munn et al., 2002).
T Helper Cell ExpansionTregs which arise naturally in the thymus (e.g., CD4CD25
T cells, further discussion below). Similar regulatory An obvious role for cytokines in allogeneic responses,
and indeed their first identified role for T cells, is topopulations have been described in models of autoim-
mune disease (Th3 cells), and their suppressive effect promote T cell proliferation. Limiting the expansion of
effector T cells is an integral part to any approach towardhas been associated with a number of cytokines, partic-
ularly IL-10 and TGF- (Cobbold and Waldmann, 1998; promoting tolerance, but until recently, it has been un-
clear which cytokines, if any, might be specifically and,Josien et al., 1998; Roncarolo and Levings, 2000). Induc-
ible Tregs are likely to mediate the occurrence of anti- if possible, nonredundantly important for T cell expan-
sion in vivo. The cytokines which can act as T cell growthgen-specific hyporesponsiveness in human T lympho-
cytes in vivo after injection of antigen-loaded immature factors are primarily those whose multimeric receptor
complexes contain the common  (c) chain, e.g., IL-2,DCs (Dhodapkar et al., 2001).
Although the extent of maturation of DCs undoubtedly IL-4, IL-7, IL-15, and IL-21. IL-2 was the first such cyto-
kine identified. Its discovery and the production of anti-plays an important role in determining the decision be-
tween tolerance and immunity, there also exists consid- bodies against the  chain of the IL-2R (CD25) prompted
studies which demonstrated that anti-CD25 mAbs coulderable evidence indicating that specific DC subsets may
suppress T cell responses independent of their matura- induce transplantation tolerance (Kupiec-Weglinski et
al., 1987; Reed et al., 1989). Initially, it was assumedtion state. CD8 DCs can in certain models induce toler-
ance of CTLs upon crosspresentation of exogenous an- that this was mediated by blockade of clonal expansion
of pathogenic alloreactive T cells. However, a varietytigen. The tolerizing potential of this DC subset appears
to be related to their ability to promote deletion of the of lines of evidence subsequently indicated a far more
complex situation. First, calcineurin inhibitors such asactivated CD8T cells (Heath and Carbone, 2001). There
is also accumulating evidence for the existence of a cyclosporine and tacrolimus are potent inhibitors of IL-2
production, yet they fail to induce tolerance in micediscrete population of DCs expressing the enzyme ido-
leamine 2,3-dioxygenase (IDO) which constitutes the and humans. Second, IL-2-deficient, as well as IL-2/
IL-4 doubly deficient mice readily reject heart and isletrate-limiting step in the catabolism of tryptophan. Sev-
eral reports have now documented the role of IDO in allografts (Li et al., 1998a). Indeed, IL-2-deficient animals
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are in fact difficult to tolerize (see below). Third, it is and IL-7 have been reported to play a role in activated
T cell survival in vivo and as such can directly regulateclear that IL-2 is not the only, or perhaps even the most,
important in vivo growth factor for activated T cells. the clonal size of alloresponsive T cells (Vella et al.,
1998). The overlapping effects of these cytokines areWhile the use of IL-2 by T cells may predominate in vitro
where T cells themselves are the source of cytokines, thought to be linked to the shared expression of a com-
mon  chain by their respective receptors. Redundancyin vivo T cell proliferation appears to be much more
dependent on IL-15, which is produced by diverse cell of function between these related cytokines may help
explain why strategies which target expression of a sin-types such as APCs and endothelial cells (Li et al.,
2001a). gle family member have proved largely unsuccessful in
inducing allospecific tolerance (Li et al., 1998a; SteigerSo how does anti-CD25 work? It is important to re-
member that in fact there is a hierarchy of tolerance et al., 1995). In support of this hypothesis, recent studies
have demonstrated that blockade of  chain signalingsusceptibility in murine models: liver kidney heart
islet  skin. Anti-CD25 by itself works only in more induces the long term survival of islet allografts while
inducing T cell apoptosis (Li et al., 2000). Similarly, ad-permissive models. A recent study may provide some
insight into this. Here, it was found that anti-CD25 lysed ministration of a humanized monoclonal antibody, which
blocks signaling through the IL-2R chain, prolongs re-activated CD25 effector T cells, while also targeting
CD25 Tregs (Zheng et al., 2003). In contrast, use of nal allograft survival in cynomolgus monkeys (Tinubu et
al., 1994). As the IL-2R  chain is shared by the receptorsan agonistic IL-2/Fc fusion protein selectively targeted
CD25 effector T cells while sparing CD25 Tregs and for both IL-2 and IL-15, this agent inhibits both the dis-
crete and overlapping effects of these cytokines onpromoting allograft survival in a very stringent model.
This approach exploits the ability of IL-2 to induce acti- T cell-mediated immune responses (Waldmann et al.,
2001). These observations indicate that it may be morevation-induced cell death (AICD) in effector T cells while
promoting the survival of CD25 Tregs. efficient to target multiple cytokines over individual cyto-
kine pathways as a means of inducing tolerance.T Cell Survival
In the last several years, a very complex story has The question of T cell survival may be particularly
important for transplantation tolerance. Recently, weemerged regarding the ability of cytokines to alternately
promote T cell survival and death and the role these and others have demonstrated the necessity of a reduc-
tion in alloresponsive T cell clone size through deletionfunctions play in the net effect of cytokines on trans-
plantation tolerance (Figure 2). Particular attention has as a prerequisite for achieving tolerance (Li et al., 1999;
Wells et al., 1999; Dai et al., 1998). In these studies,focused on IL-2, and much of this evidence stems from
investigations in mice, which are deficient in expression we found that mice whose T cells were defective in
undergoing either AICD (IL-2-deficient mice) or in under-of IL-2 or the  chain of the IL-2R. Such mice have a
severe lymphoproliferative disorder caused by an ap- going apoptosis in response to cytokine withdrawal
(Bcl-xL transgenic recipients) resisted tolerance induc-parent failure to clear activated T cells from the periph-
ery through AICD (Sadlack et al., 1995; Willerford et al., tion to MHC mismatched allografts by costimulatory
blockade. Furthermore, calcineurin inhibition, which1995). T cells from IL-2/ mice were observed to be
insensitive to Fas-mediated apoptosis in vitro leading blocks the induction of apoptosis following T cell activa-
tion, antagonized the ability of costimulatory blockadeto the hypothesis that a major function of IL-2R signaling
in vivo is to prime activated T cells for Fas-induced to induce tolerance. Conversely, rapamycin, which po-
tentiates AICD induced through costimulatory blockade,apoptosis (Refaeli et al., 1998). At present, it does not
appear that any of the other  chain cytokines can also enhanced the tolerizing potential of this approach in
highly resistant models such as skin. The importanceact as a feedback regulator of clonal expansion similar
to IL-2. Interestingly, the other major cytokine associ- of cell death in the induction of tolerance further explains
why both IL-2 and IFN-, proinflammatory cytokinesated with an inflammatory immune response, IFN-, also
has an important role in regulating T cell expansion, which might be considered a barrier to tolerance induc-
tion, can in fact, through their ability to promote T cellas revealed by studies in IFN--deficient mice, which
display enhanced proliferation in response to allogeneic apoptosis, also facilitate rather than impede allograft
acceptance. These observations suggest that thesestimulation in vitro when compared to their wild-type
counterparts (Konieczny et al., 1998). so-called “proinflammatory” cytokines play an addi-
tional, if not predominantly limiting, role in the contextHowever, while IL-2 has the ability to prime T cells to
ultimately undergo AICD, its initial role in the immune of an in vivo alloimmune reaction (Figure 2).
During the course of a normal T cell immune response,response is actually to promote T cell survival, primarily
by upregulation of the antiapoptotic gene Bcl-2 (Mueller initiation is followed by clonal expansion and a subse-
quent large-scale apoptotic cascade, which memoryet al., 1996; Van Parijs et al., 1999). Expression of Bcl-2
and the related gene Bcl-xL, which is upregulated cells escape. This is likely due to an inherent survival
advantage of memory T cells over their effector counter-through CD28 costimulation (Boise et al., 1995), enables
activated cycling T cells to survive in cytokine-depleted parts, and as a consequence memory cells may evade
tolerizing strategies, which induce the deletion of allore-environments. Thus, the net effects of IL-2 are both time
and context dependent. Early in the immune response, active T cells during the induction phase. While the re-
quirements for the generation of CD4 T cell memoryand in the face of limiting cytokines, IL-2 promotes T cell
growth and survival. Later in the immune response, and remain largely undefined, it is increasingly evident that
IL-15 plays a central role in the generation and survival ofin the face of continued antigenic stimulation, IL-2 pro-
motes cell death. CD8 memory cells (Figure 2) (Schluns and Lefrancois,
2003). In contrast, IL-2 has been reported to have littleIn addition to IL-2, other cytokines such as IL-15, IL-4,
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Figure 2. Role of Cytokines at Major Decision Nodes between Allograft Tolerance and Rejection
Cytokines play a pivotal role in the development of both transplant tolerance and rejection by regulating critical points during the generation
of an allospecific immune response. Proinflammatory cytokines such as IL-12 and IL-15 appear to exclusively promote graft rejection through
directing T effector differentiation or promoting expansion, survival, and memory development, respectively. Conversely, immunosuppressive
cytokines such as IL-10 and TGF can promote tolerance through mediating regulatory T cell function. IL-2 can either be tolerogenic (priming
for AICD and regulating Treg homeostasis) or promote rejection (effector T cell expansion and survival). The pleiotropic effects of IL-2 appear
to be temporally and contextually dependent.
or no effect on CD8 memory cell homeostasis, indicat- ally linked to transplant tolerance; however, many sub-
sequent investigations indicate that the situation ising that this function is specific to IL-15 and not shared
by related cytokines (Dai et al., 2000). An important fea- somewhat more complex. For example, in most circum-
stances, deliberate skewing of alloimmunity toward Th2ture of memory T cells is their decreased requirement
for costimulation to induce optimal responses. In fact, responses either through antagonism of IL-12 signaling
or in vivo administration of stable Th2 cytokines stillcostimulatory blockade has been demonstrated to be
ineffective in preventing allograft rejection in certain results in rejection of MHC mismatched grafts (Li et al.,
1998b; Piccotti et al., 1996; Zheng et al., 1995). However,models and this resistance may be mediated by CD8
memory T cells (Valujskikh et al., 2002; Zhai et al., 2002) redirecting a Th1 response toward a Th2 response is by
itself sufficient to prevent graft rejection across selectedOther studies have demonstrated that antagonism of
IL-15 signaling and/or lysis of IL-15R cells can promote minor histocompatibility barriers (Li et al., 1998b). We
have interpreted this in the context of the size of theallospecific tolerance in models which are resistant to
the effects of costimulatory blockade (Ferrari-Lacraz et alloreactive T cell pool, being much larger in across
MHC barriers than across minor histocompatibility dif-al., 2001; Smith et al., 2000). However, it has not been
conclusively proven that all of these effects are medi- ferences (Kishimoto et al., 2002). Consistent with an
important role for pool size, while costimulatory block-ated specifically through memory cells, as primary CD8
T cells also have a reduced requirement for costim- ade cannot induce long-term MHC mismatched allograft
survival in models where T cell apoptosis is impairedulation when compared to their CD4 counterparts
(Newell et al., 1999). (see above), CTLA4Ig is very effective at inducing long-
term allograft survival across mH barriers in these sameT Helper Cell Differentiation
Th2 responses are often observed in the context of long- models (IL-2- or IFN--deficient recipients or Bcl-xL-
transgenic recipients). Thus, the relative ease of creatingterm allograft acceptance and/or tolerance. This initially
led to the proposal that Th2 immune deviation was caus- a tolerant state, and the requirements to do so, may
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differ depending on quantitative issues (e.g., the number TCRCD4CD8 T cells after transplantation (Colovai
et al., 2000; Zhang et al., 2001). Tregs have been reportedof alloreactive cells). Nonetheless, other reports indicate
that Th2 alloreactive clones can be effective mediators to have a variety of actions on immune effector cells,
most notably the inhibition of proliferation and cytokineof graft rejection (Barbara et al., 2000) and murine strain
specific differences in the Th1 versus Th2 dominance production. However, the precise mechanisms of immu-
nosuppression by Treg subsets have yet to be defined,of allograft rejection have been reported, with either
type of response culminating in graft destruction (Wang and it is becoming increasingly clear that various cyto-
kines play an integral role in the development, homeo-et al., 2003). While these studies make it clear that Th2
responses can be directed at allograft rejection, the stasis, and function of these cells.
Most recent studies on Tregs have focused on a natu-ultimate role of Th2 cytokines in graft rejection versus
tolerance remains unresolved. Any such role is undoubt- rally occurring subset of CD4 T cells which constitu-
tively express the IL-2R chain (CD25). While CD4CD25edly related to a number of parameters including the
size of the alloreactive T cell repertoire, the extent and Tregs were originally characterized as being important
in the maintenance of self-tolerance (Takahashi et al.,types of antigenic disparities between donor and recipi-
ent, and the tissue being transplanted, as well as the 1998), they are also recognized to play a role in many
models of allograft tolerance. The suppressive effect ofbackground genes of the recipient which influence the
nature of the allograft response. these cells appears to be cell contact dependent, and
there is evidence to suggest that Treg-mediated produc-There is, however, one well-described system in
which immune deviation can induce allograft tolerance tion of IL-10 and cell surface expression of TGF may
play an important role in vivo. Inhibitory antibodiesand whose mechanism is understood at a cellular level.
The term anterior chamber-associated immune devia- against both IL-10 and its cognate receptor have been
shown to inhibit the suppressive effects of Treg cells intion (ACAID) was coined to describe a naturally oc-
curring phenomenon which facilitates the transplanta- skin allograft models (Hara et al., 2001; Kingsley et al.,
2002). However, a defined role for IL-10 in transplanta-tion of MHC-mismatched corneas with the absence of
a proinflammatory T cell response (Streilein et al., 2002). tion tolerance remains controversial, perhaps reflecting
both the immunostimulatory and immunosuppressiveACAID occurs as a result of a number of factors, which
combine to promote the development of a regulatory properties of this cytokine (Figure 4). Accordingly, while
some studies reveal the beneficial effects of IL-10 signal-response by APCs normally resident within the anterior
chamber of the eye. APCs at this site are phenotypically ing in enhancing graft survival many others suggest neu-
tral or even detrimental effects (Moore et al., 2001). Inter-modulated by the high levels of constitutive expression
of TGF- in the intraocular microenvironment, leading estingly, a homolog of IL-10 expressed in many viral
genomes appears to retain the immunosuppressiveto the downregulation of T cell costimulatory factors
such as CD40 and a failure to secrete IL-12. After antigen properties of this cytokine without the capacity for
immunostimulation observed with endogenous IL-10.capture these APCs are mobilized to leave this environ-
ment and migrate to the spleen. Here the APCs continue Indeed, studies involving ectopic expression of viral
IL-10 within the allograft have had considerably moreto secrete immunosuppressive cytokines, in particular,
TGF- and IFN/, and upon initial interaction with NK success in prolonging graft survival than models which
manipulate endogenous IL-10 (Bromberg, 1995; De-T cells attract antigen-specific CD4 and CD8 T cells.
The net effect of such phenotypic alterations in antigen Bruyne et al., 1998; Wang et al., 1999). The observation
that Treg cells express a cell surface bound isoformpresentation is the development of an immunoregula-
tory T cell response in place of a Th1-type response. of TGF has led to the hypothesis that it may be the
mechanism through which cell contact-mediated sup-Immunoregulatory T cells are induced to produce cyto-
kines such as TGF and IL-10 and disseminate from the pression occurs. Indeed, a role for TGF in mediating
suppression by Tregs has been described in a numberspleen to contribute to the maintenance of tolerance
against the antigen in question. of allograft models (Jonuleit et al., 2002; Josien
et al., 1998). However, it is noteworthy that functionalRegulatory T Cell Homeostasis and Function
While deletional events during the induction phase of CD4CD25 T regs are present in mice with deficiencies
in both IL-10 and TGF, perhaps indicating that thesetransplantation tolerance prevent early rejection and fa-
cilitate graft acceptance, an active process of immune cytokines alone are not solely responsible for suppres-
sion (Piccirillo et al., 2002; Suri-Payer and Cantor, 2001).regulation is required to maintain host tolerance to trans-
planted tissues over a prolonged time period. It should also be noted that most reported data would
also be consistent with a model in which cytokines suchInitial observations which established that tolerance
to alloantigens is transferable to a naive animal by T cells as IL-10 and TGF are not necessarily direct products
of the Tregs, but may be induced by Tregs in otherprovided evidence of the existence of immunoregulatory
mechanisms within the host’s T cell repertoire (Qin et target populations.
Along those lines, an interesting feature of regulatoryal., 1993). The existence of distinct T cell subsets, which
function to restrict the expansion of effector T cells is T cells in the context of allograft transplantation is an
apparent ability to promote the development of an im-now widely accepted, and the identification and mecha-
nism of action of such regulatory T cell (Treg) subsets munosuppressive phenotype in otherwise nonregula-
tory T cells. Furthermore, an allounresponsive state canremain areas of intense investigation. While the majority
of Treg subsets defined thus far develop within the CD4 be generated without subjecting the host to the entire
range of donor graft antigens. Preexposure to a singlepopulation, regulatory activity is by no means exclu-
sively restricted to CD4 T cells. Indeed, regulatory ac- antigen expressed within the graft can be sufficient
(Madsen et al., 1988). This linked suppression appearstivity has also been demonstrated in CD8 as well as in
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Figure 3. The Phenomenon of Linked Sup-
pression
Linked suppression refers the induction of
tolerance to a third party alloantigen B by
regulatory T cells recognizing alloantigen A
when both antigens are processed and pre-
sented by the same antigen-presenting cell.
This effect is mediated at least in part by the
secretion of cytokines such as TGF and
IL-10 by the regulatory T cells which cause
the effector cell recognizing alloantigen B to
become hyporesponsive and perhaps de-
velop a regulatory phenotype (infectious tol-
erance).
to act via inducing new T cells which enter the host Cytokines as Potential Therapeutic Targets
Arguably, the greatest single barrier to the induction ofrepertoire after transplantation to develop a regulatory
rather than effector phenotype (Figure 3). The exact allospecific tolerance is the extraordinarily large number
of responding T cells with direct allospecificity. Mount-mechanism by which linked suppression occurs has
not been defined; however, it has been reported that ing evidence indicates that in order for tolerance to be
induced an initial wave of deletion of effector T cells isincreased Th2 type cytokines (IL-4 and IL-10) are present
at the graft site in models where tolerance is achieved required. This creates a more level playing field on which
regulatory T cells can suppress the now reduced numberthrough such mechanisms (Onodera et al., 1997). IL-10
and TGF have also been implicated in the suppressive of alloreactive cells available and primed for graft de-
struction.function of these induced Treg subsets (Dieckmann et
al., 2002; Jonuleit et al., 2002). At present, the most effective single therapeutic
agents which prolong graft survival are calcineurin inhib-In addition to the ability of cytokines to mediate sup-
pressive functions of regulatory T cells, there is mount- itors, such as cyclosporine A and tacrolimus. The pri-
mary effect of these agents is to broadly block T celling evidence that cytokines, in particular IL-2, play a
critical role in the development and homeostasis of Treg cytokine gene transcription by inhibiting activation of
NFAT transcription factors. However, cytokines bothcells (Figure 2). CD4CD25 T cells are not detectable
in IL-2/ mice, which suffer from a severe lymphopro- promote and terminate immune responses. This is well
demonstrated by the findings that calcineurin inhibitorsliferative disorder and autoimmune disease. Signifi-
cantly, the generation of IL-2/ mice on a TCR-trans- abrogate tolerance induction by costimulatory block-
ade, in association with inhibition of T cell apoptosisgenic background blunts the progression of autoimmune
disease, presumably because of the lack of autoreactive (Li et al., 1999).
It is likely that tolerance-opposing effects of cal-T cells generated naturally in the thymus (Wolf et al.,
2001). Malek et al. have demonstrated the requirement cineurin inhibitors are multifactorial. For example, by
blocking the production of IL-2, these agents may pre-of IL-2R signaling through the  chain of the receptor
for the development of CD4CD25 Tregs in vivo (Malek vent T cell priming for AICD which might otherwise occur
during the natural evolution of an immune response oret al., 2002), and it has also been reported that IL-2
contributes to the survival of Tregs in the periphery (Al- as a deliberate effect by other pharmacological or bio-
logical agents. The inability to tolerize IL-2-deficientmeida et al., 2002; Murakami et al., 2002). A characteris-
tic feature of CD4CD25 Tregs is their hypoproliferative mice by costimulatory blockade is consistent with this
concept. In addition, it is likely that agents which targetresponse to IL-2 stimulation in vitro, despite constitutive
expression of all three chains of the IL-2R. Proliferation costimulatory molecules, such as CTLA4Ig or anti-
CD154, are effective in inducing peripheral tolerance byof Tregs can be induced in vitro upon stimulation
through either the TCR or TNFR superfamily member targeting activated T cells. Inhibition of costimulatory
pathways decreases secretion of prosurvival cytokinesGITR when either stimulus is used in combination with
IL-2 (McHugh et al., 2002). While recent studies have rendering activated T cells susceptible to apoptosis due
to cytokine withdrawal. By preventing the early stageshighlighted the requirement for TCR-derived signals to
induce Treg expansion in vivo (Walker et al., 2003), it is of T cell activation, calcineurin inhibitors may prevent
the dependency on cytokines that T cells develop uponhighly likely that such a stimulus alone is not sufficient
to drive Treg expansion and that a secondary cytokine cell cycle entry. As a result, costimulatory blockade does
not result in T cell apoptosis in the context of calcineurinsignal is necessary. Whether IL-2 contributes to cell
cycle progression or simply functions to maintain Treg inhibition (Li et al., 1999).
An additional major problem with the use of nonspe-viability thus contributing to efficient expansion, driven
by another cytokine (e.g., IL-15), remains unclear. cific immunosuppressive agents is the diverging effects
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Figure 4. Cytokines Regulate the Polarity of the Immune Response toward the Transplant
Many studies demonstrate that IL-10 plays a role in the induction of T cell tolerance due to its immunosuppressive function; however, other
reports indicate that it may also act in an immunostimulatory fashion to promote rejection. On the other hand, it is believed that IL-15 promotes
the development of a solely proinflammatory T cell response leading to allograft rejection. IL-2 can induce both tolerizing and proinflammatory
effects, depending on the phase and context of the response, demonstrating its critical role in determining the fate of the allograft.
of such regimens on different T cell subsets such as the induction of susceptibility to AICD of activated ef-
fector T cells. As a result, when administered in combi-Tregs. As IL-2 is critical for Treg development and sur-
vival in the periphery, any therapy which inhibits IL-2 nation with strategies to induce costimulatory blockade,
rapamycin is permissive (if not additive) for promotingproduction is likely to have a detrimental effect on the
maintenance of a regulatory T cell pool. Thus, while cell death and inducing peripheral tolerance (Li et al.,
1999). The effects of selective inhibition of IL-2 -depen-calcineurin inhibition may be effective in preventing the
progression of an alloreactive T cell response during dent signaling with rapamycin on Treg cells are largely
undefined. However, it is possible that they may differthe acute phase after allograft transplantation, it may
also prevent the equally important maintenance of allo- from the effects observed in activated effector T cells
given that CD4CD25 T cells have somewhat distinctgraft tolerance through its negative effect on Treg popu-
lations (Figure 4). responses to IL-2R stimulation.
The redundancy of cytokine functions, where any ofA more rewarding approach may be to target cytokine
signaling distal to receptor engagement, when selected several cytokines can promote T cell growth and sur-
vival, as well as the pleiotropic nature of specific cyto-effects of intracellular cytokine signaling may be specifi-
cally blocked while allowing those pathways which are kines, which can have both time- and context-depen-
dent enhancing and terminating effects on immuneimportant to tolerance induction and maintenance to
remain intact. Rapamycin is one such agent which responses, has made it very difficult to target specific
individual cytokines or their receptors to promote trans-blocks IL-2-mediated proliferation without preventing
Table 1. Roles of Major Cytokines in the Development of Transplant Tolerance or Rejection
Cytokine Tolerance Rejection Reference
Il-2   Wells et al., 1999; Malek et al., 2002; Refaeli et al., 1998
IFN-   Konieczny et al., 1998; Akira et al., 2001
IL-10   Moore et al., 2001; Bromberg, 1995
TGF   Jonuleit et al., 2002
IL-15   Ferrari-Lacraz et al., 2001
IL-12   Banchereau and Steinman, 1998
IL-4   Onodera et al., 1997; Vella et al., 1998
The role of cytokines in transplantation tolerance and rejection is based on the reported influence on T cell-mediated responses as well as
investigation of their respective roles in models of transplantion.
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DeBruyne, L.A., Li, K., Chan, S.Y., Qin, L., Bishop, D.K., and Brom-plantation tolerance (Table 1). Our own belief is that the
berg, J.S. (1998). Lipid-mediated gene transfer of viral IL-10 prolongskey to generating and sustaining tolerance is reducing
vascularized cardiac allograft survival by inhibiting donor-specificthe overall number of alloreactive T cells while allowing
cellular and humoral immune responses. Gene Ther. 5, 1079–1087.
for the development of immunoregulatory mechanisms,
Dhodapkar, M.V., Steinman, R.M., Krasovsky, J., Munz, C., and
some of which are likely to involve Th2 cytokines. In Bhardwaj, N. (2001). Antigen-specific inhibition of effector T cell
this context, the emergence of Th2 responses may be function in humans after injection of immature dendritic cells. J.
viewed as permissive for tolerance. A recent report dem- Exp. Med. 193, 233–238.
onstrating tolerance induction in a very stringent model Dieckmann, D., Bruett, C.H., Ploettner, H., Lutz, M.B., and Schuler,
through the combined blockade of IL-15 signals (critical G. (2002). Human CD4()CD25() regulatory, contact-dependent
T cells induce interleukin 10-producing, contact-independent typefor T cell proliferation in vivo) and the use of an agonistic
1-like regulatory T cells. J. Exp. Med. 196, 247–253.IL-2/Fc fusion protein to promote the selective lysis of
Dunne, A., and O’Neill, L.A. (2003). The interleukin-1 receptor/Toll-nonregulatory CD25 T cells is just one example of how
like receptor superfamily: signal transduction during inflammationthis may be achieved (Zheng et al., 2003). Clearly, a
and host defense. Science’s STKE, http://stke.sciencemag.org/cgi/
greater understanding of the specific roles these cyto- content/full/OC_sigtrans;2003/171/re3.
kines play in the context of allograft transplantation may
Ferrari-Lacraz, S., Zheng, X.X., Kim, Y.S., Li, Y., Maslinski, W., Li,
allow other specific targeting for therapeutic strategies X.C., and Strom, T.B. (2001). An antagonist IL-15/Fc protein prevents
in the future. costimulation blockade-resistant rejection. J. Immunol. 167, 3478–
3485.
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